IDXX vs KVYO · P/E 40, rev $2.36B vs rev $1.23B
IDEXX Laboratories Inc (IDXX) versus Klaviyo, Inc. (KVYO) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Klaviyo, Inc. (KVYO) is a software - infrastructure company listed on US.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported KVYO revenue for 2025-12-31 was $1.23B. Net income was -$31.8M. Revenue was up 31.6% from 2024-12-31 to 2025-12-31. KVYO currently screens at market cap $9.88B.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. KVYO currently screens at market cap $9.88B.
Not investment advice. Open the IDXX and KVYO stock pages for the full models.
Not investment advice.